000			02783cam a22004697i 4500
001			22290544
003			OSt
005			20231004020021.0
008			211029s2019 enka b 001 0 eng c
010			_a 2021277562
015			_aGBB8N4782 _2bnb
016	7		_a101742274 _2DNLM
016	7		_a019173449 _2Uk
020			_a9780128126264 _q(hardback)
035			_a(OCoLC)on1079222648
040			_aNLM _beng _cNLM _erda _dOCLCF _dLOY _dUKMGB _dOCLCO _dGUA _dOCLCA _dDLC
042			_apcc
050	0	0	_aRM301.3.G45 _b.P4228 2019
060	0	0	_a2019 B-401
060	1	0	_aQV 38.5
100			_aLam, Y. W. Francis _eeditor.
130	0		_aPharmacogenomics (Lam)
245	1	0	_aPharmacogenomics : _bchallenges and opportunities in therapeutic implementation /
250			_aSecond edition.
264		1	_aLondon : _bELSEVIER ACADEMIC Press, _c2019.
300			_axvi, 426 pages : _billustrations ; _c24 cm
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
504			_aIncludes bibliographical references and index.
520			_aPharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations. With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation. -- _cSource other than the Library of Congress.
650		0	_aPharmacogenomics.
650	1	2	_aPharmacogenetics _xmethods.
650	2	2	_aDrug Design.
650	2	2	_aPharmacological Phenomena _xgenetics.
650		7	_aPharmacogenomics. _2fast _0(OCoLC)fst01060245
700	1		_aScott, Stuart A. _q(Stuart Alexander), _eeditor.
700	1		_aCavallari, Larisa H.; _eeditor.
906			_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg
942			_2lcc _cBK _03
999			_c2698 _d2698